BIOMAT Database Logo BIOMAT Database Logo

N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists. 2007

Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
Department of Bioorganic Chemistry, CV Therapeutics Inc., 3172 Porter Drive, Palo Alto, CA 94304, USA. elfatih.elzein@cvt.com

A series of new selective, high affinity A(1)-AdoR agonists is reported. Compound 23 that incorporated a carboxylic acid functionality in the 4-position of the pyrazole ring displayed K(iL) value of 1 nM for the A(1)-AdoR and >5000-fold selectivity over the A(3) and A(2A)-AdoRs. In addition, compound 19 that incorporated a carboxamide functionality in the 4-position of the pyrazole ring displayed subnanomolar affinity for the A(1)-AdoR (K(iL)=0.6 nM) and >600-fold selectivity over the A(3) and A(2A)-AdoRs.

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D058907 Adenosine A1 Receptor Agonists Compounds that bind to and stimulate ADENOSINE A1 RECEPTORS.

Related Publications

Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
April 2009, Journal of medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists.
September 2004, Journal of medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists.
February 2008, Bioorganic & medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
A Structure-Activity Relationship Study of Bitopic N6-Substituted Adenosine Derivatives as Biased Adenosine A1 Receptor Agonists.
March 2018, Journal of medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.
January 1998, Journal of medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
New 2,N6-disubstituted adenosines: potent and selective A1 adenosine receptor agonists.
April 2002, Bioorganic & medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
Examining the Role of the Linker in Bitopic N6-Substituted Adenosine Derivatives Acting as Biased Adenosine A1 Receptor Agonists.
July 2022, Journal of medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists.
October 1985, Journal of medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.
March 1996, Journal of medicinal chemistry,
Elfatih Elzein, and Rao Kalla, and Xiaofen Li, and Thao Perry, and Tim Marquart, and Mark Micklatcher, and Yuan Li, and Yuzhi Wu, and Dewan Zeng, and Jeff Zablocki
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
August 1999, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!